4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-062720
General Counsel and Secretary acquired 22,026 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KASINGER JAMES R. General Counsel and Secretary | 2020-12-09 | Option exercise | +22,026 | $13.62 | $299,994 | 22,415 | D |
| Derivatives | |||||||
| KASINGER JAMES R. General Counsel and Secretary | 2020-12-09 | Option exercise · Stock Option (right to buy) | −22,026 | 100,974 | D | ||
Loading xslF345X03/doc4.xml…